Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer

NCT00006267 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped Never activated.

Conditions

Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

DRUG: rubitecan

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]